Physician profile

Rosetta Goba

Family · Dallas, TX

NPI 1942828751

$467.85

in general payments reported to CMS, 2019-2025

12 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$99.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $79.54 2023-2024
Forte Bio-Pharma LLC $45.28 2021
Collegium Pharmaceutical, INC. $45.09 2021
Virtus Pharmaceuticals LLC $44.35 2021
Scilex Pharmaceuticals INC. $42.90 2022
Biodelivery Sciences International, INC. $40.22 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $36.43 2022
Nevro Corp. $35.71 2021
Medtronic, INC. $34.81 2022-2023 Kyphon Express II Kyphopak Tray
Arbor Pharmaceuticals, INC. $25.41 2021
Grt US Holding, INC. $24.96 2022
Pacira Pharmaceuticals Incorporated $13.15 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rosetta Goba

$467.85

in general payments reported 2019-2025

Years
2021-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/10439296/rosetta-goba

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.